Neuberger Berman Group
OM icon

Neuberger Berman Group’s Outset Medical OM Stock Holding History

Neuberger Berman Group’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,961
Closed -$3.27M – 1860
2023
Q2 		$3.27M Buy
9,961
+3,117
+46% +$951K ﹤0.01% 982
2023
Q1 		$1.89M Sell
6,844
-375
-5% -$138K ﹤0.01% 1103
2022
Q4 		$2.8M Buy
+7,219
New +$2.04M ﹤0.01% 994
2022
Q3 		– Sell
-9,595
Closed -$2.14M – 1883
2022
Q2 		$2.14M Buy
9,595
+339
+4% +$146K ﹤0.01% 1089
2022
Q1 		$6.3M Buy
9,256
+1,079
+13% +$649K 0.01% 910
2021
Q4 		$5.54M Sell
8,177
-593
-7% -$439K ﹤0.01% 949
2021
Q3 		$6.38M Buy
8,770
+8,301
+1,770% +$5.66M 0.01% 899
2021
Q2 		$352K Buy
+469
New +$358K ﹤0.01% 1562

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Neuberger Berman Group's OM Position: Q3 2023 in Review

Neuberger Berman Group sold out of Outset Medical (OM) in Q3 2023, closing a stake of 9,961 shares — an estimated $3.27M sold.

Neuberger Berman Group first reported a position in OM in Q2 2021 and held it in 8 quarters. The position peaked at $6.38M in Q3 2021. 152 funds tracked by Wall St. Rank hold OM as of Q3 2023.

  • Neuberger Berman Group reported no remaining Outset Medical position as of Q3 2023 after selling out during the quarter.
  • Neuberger Berman Group sold 9,961 Outset Medical shares in Q3 2023, an estimated $3.27M.
  • Neuberger Berman Group first reported a position in Outset Medical in Q2 2021 and held it in 8 quarters.
  • Neuberger Berman Group's Outset Medical position peaked at $6.38M in Q3 2021.
  • 152 funds tracked by Wall St. Rank held Outset Medical as of Q3 2023.

Based on Neuberger Berman Group's 13F filing for Q3 2023, filed 14 Nov 2023.